Skip to main content
Clinical Trials/NCT01999647
NCT01999647
Completed
Not Applicable

Intraneural Injection of Ropivacaine for Subgluteal Sciatic Nerve Block Leads to Faster Onset and Higher Success Rates: a Randomized, Controlled Trial

University of Parma1 site in 1 country64 target enrollmentDecember 2011

Overview

Phase
Not Applicable
Intervention
Perineural Injection for Subgluteal Sciatic Nerve Block
Conditions
Orthopedic Disorders
Sponsor
University of Parma
Enrollment
64
Locations
1
Primary Endpoint
Onset Time of Sciatic Nerve Block
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

This study was designed to assess whether the injection of local anesthetic into the nerve (intraneural), as opposed to around it (perineural), requires a shorter time to develop surgical anesthesia of the lower leg.

The investigators will compare the two types of injection using the same drug, so as to determine if there is an actual difference onset time. They will also examine the overall success rate of either kind of sciatic nerve blocks as the sole anesthetic for non-emergent orthopedic surgery.

The safety of these procedures will be examined by in-hospital and phone-call follow-up contacts.

Detailed Description

This will be a randomized, controlled, patient- and observer-blinded trial assessing block characteristics after intra- or perineural injection of ropivacaine for subgluteal sciatic nerve blocks performed for elective surgery of the lower limb.

Registry
clinicaltrials.gov
Start Date
December 2011
End Date
December 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marco Baciarello

Assistant Professor of Anesthesiology, Critical Care and Pain Medicine

University of Parma

Eligibility Criteria

Inclusion Criteria

  • Undergoing non-emergent orthopedic procedure of knee, leg, foot with thigh tourniquet
  • ASA Physical Status Class I-III
  • Consenting to surgery under peripheral nerve block anesthesia (sciatic + femoral/saphenous block)

Exclusion Criteria

  • Unable to understand or communicate for the purpose of the study
  • Exhibiting any neurological disturbance of the ipsilateral lower extremity
  • Inability to satisfactorily image the sciatic nerve in the opinion of the attending anesthesiologist

Arms & Interventions

Perineural

Patients in this group will receive a perineural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Perineural Injection for Subgluteal Sciatic Nerve Block

Perineural

Patients in this group will receive a perineural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Femoral Nerve Block

Perineural

Patients in this group will receive a perineural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Patient-Controlled Postoperative Analgesia

Perineural

Patients in this group will receive a perineural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Ropivacaine

Intraneural

Patients in this group will receive an intraneural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Intraneural Injection for Subgluteal Sciatic Nerve Block

Intraneural

Patients in this group will receive an intraneural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Femoral Nerve Block

Intraneural

Patients in this group will receive an intraneural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Patient-Controlled Postoperative Analgesia

Intraneural

Patients in this group will receive an intraneural injection for subgluteal sciatic nerve block under real-time, short-axis, in-plane ultrasound guidance, in addition to a femoral nerve block and patient-controlled postoperative analgesia. Ropivacaine will be used for the sciatic nerve block, whereas the choice of agent for the femoral nerve block is left to the attending anesthesiologist.

Intervention: Ropivacaine

Outcomes

Primary Outcomes

Onset Time of Sciatic Nerve Block

Time Frame: ≤30 minutes after block performance

Time to onset of sciatic nerve anesthesia, defined as both following criteria: * Sensory: does not feel pain or discomfort when pricked with a 25G needle. * Motor: able to slightly curl toes; unable to flex the ankle.

Secondary Outcomes

  • Success Rate of Sciatic Nerve Blocks(≤30 min after block performance)
  • Incidence and Prevalence of Neurologic Disturbances(30 days after anesthesia performance)
  • Differences in Time to Resolution of Sciatic Nerve Block(<12 h)

Study Sites (1)

Loading locations...

Similar Trials